Sort   by:  
 Page size 
UnknownGenetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.
Not available
S-EPMC4911928 | biostudies-literature
UnknownNeurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions.
Not available
S-EPMC10519742 | biostudies-literature
UnknownNeuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Not available
S-EPMC11567150 | biostudies-literature
UnknownNeuronal α-Synuclein Disease Stage Progression over 5 Years.
Not available
S-EPMC12273616 | biostudies-literature
UnknownEvidence for 28 genetic disorders discovered by combining healthcare and research data.
Not available
S-EPMC7116826 | biostudies-literature
UnknownAlemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Not available
S-EPMC5109953 | biostudies-literature
UnknownCAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.
Not available
S-EPMC3306163 | biostudies-literature
UnknownEffects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164 | biostudies-literature
UnknownExpanded encyclopaedias of DNA elements in the human and mouse genomes.
Not available
S-EPMC7410828 | biostudies-literature
UnknownEffect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233 | biostudies-literature
Sort   by:  
 Page size